If left untreated, LVOs can cause ischemic strokes. The algorithm has the potential to significantly reduce time to treatment in these emergency scenarios.
“Rapidly rising healthcare costs continue to be a top concern for members and their employers," the nation's largest commercial insurer wrote in a recent letter to an unidentified imaging group.
The independent, nonprofit—which provides objective advice on health policy—has picked Pamela K. Woodard, MD, and David G. Kirsch, MD, PhD, for the prestigious designation.
New artificial intelligence technology could be used as a complimentary tool alongside low-dose GBCAs to enhance exams without sacrificing image quality.
Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta.
In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.
A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen.
Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.
